David Butler
Advisor to Hongene Biotech in the RNA therapeutics CDMO and raw materials space.
False
Advertisement
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
August 31, 2026
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products
4 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
